Neuroanesthesia & neurocritical care

Clinical Outcomes of Hypertonic Saline vs Mannitol Treatment Among Children With Traumatic Brain Injury

JAMA Netw OpenPublished Prospective cohort study

An erratum to this article was published (JAMA Netw Open, 1 May 2025 ↗)

Authors' conclusion

In this cohort study of children with moderate to severe TBI, the use of HTS was not associated with increased survival or improved functional outcomes compared with mannitol.

Study context

Population
Children (<18 years) with moderate to severe traumatic brain injury (TBI) (GCS ≤13) at 28 PICUs in Asia, Latin America and Europe, 2018–2022
Participants
445 children · 28 PICUs
Exposure
3% hypertonic saline (HTS) vs 20% mannitol
  • HTSn = 184
  • Mannitoln = 82reference
  • Both agentsn = 69
  • Neither agentn = 110
Outcome
Mortality and functional outcomes (discharge PCPC scores, 3-month GOS-E-Peds scores)
Methodological detailsmulticentre, inverse probability of treatment weighting (propensity score)
  • Multicentre
  • Inverse probability of treatment weighting (propensity score)

Main finding

As reported in the abstract

Mortality

P = 0.34

Observational data: associations, not effects.

Original publication

Clinical Outcomes of Hypertonic Saline vs Mannitol Treatment Among Children With Traumatic Brain Injury. JAMA Netw Open. Published 3 March 2025. doi:10.1001/jamanetworkopen.2025.0438

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.